Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Cholesterol emboli syndrome laboratory findings

Introduction

Overview

Overview

Laboratory Findings

Laboratory Findings

Biomarker Studies

References

References

  1. โ†‘ Ozkok, Abdullah (2019). “

    Cholesterol-embolization syndrome: current perspectives

    “. Vascular Health and Risk Management. Volume 15: 209โ€“220. doi:10.2147/VHRM.S175150. ISSNย 1178-2048.
  2. โ†‘ Fukumoto, Yoshihiro; Tsutsui, Hiroyuki; Tsuchihashi, Miyuki; Masumoto, Akihiro; Takeshita, Akira (2003). “The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study”. Journal of the American College of Cardiology. 42 (2): 211โ€“216. doi:10.1016/S0735-1097(03)00579-5. ISSNย 0735-1097.
  3. โ†‘ Cecioni, Ilaria; Fassio, Filippo; Gori, Stefano; Giudizi, Maria Grazia; Romagnani, Sergio; Almerigogna, Fabio (2007). “Eosinophilia in cholesterol atheroembolic disease”. Journal of Allergy and Clinical Immunology. 120 (6): 1470โ€“1471. doi:10.1016/j.jaci.2007.07.014. ISSNย 0091-6749.
  4. โ†‘ Cosio FG, Zager RA, Sharma HM (1985). “Atheroembolic renal disease causes hypocomplementaemia”. Lancet. 2 (8447): 118โ€“21. doi:10.1016/S0140-6736(85)90225-9. PMIDย 2862317. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]